Cargando…

Examining buprenorphine diversion through a harm reduction lens: an agent-based modeling study

BACKGROUND: Recent policies have lessened restrictions around prescribing buprenorphine-naloxone (buprenorphine) for the treatment of opioid use disorder (OUD). The primary concern expressed by critics of these policies is the potential for buprenorphine diversion. However, the population-level effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adams, Joëlla W., Duprey, Michael, Khan, Sazid, Cance, Jessica, Rice, Donald P., Bobashev, Georgiy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580611/ https://www.ncbi.nlm.nih.gov/pubmed/37848945 http://dx.doi.org/10.1186/s12954-023-00888-6

Ejemplares similares

Trends in Opioid Misuse Among Individuals Aged 12 to 21 Years in the US
por: Warren, Lauren Klein, et al.
Publicado: (2023)

'Diversion’ of methadone or buprenorphine: 'harm’ versus 'helping’
por: Havnes, Ingrid Amalia, et al.
Publicado: (2013)

Reducing the Complexity of an Agent-Based Local Heroin Market Model
por: Heard, Daniel, et al.
Publicado: (2014)

myEpi. Epidemiology of One
por: Bobashev, Georgiy
Publicado: (2014)

Methadone, Buprenorphine, and Street Drug Interactions with Antiretroviral Medications
por: Gruber, Valerie A., et al.
Publicado: (2010)

Enhancing the prediction of hospitalization from a COVID-19 agent-based model: A Bayesian method for model parameter estimation
por: Hadley, Emily, et al.
Publicado: (2022)

Impacts of timing, length, and intensity of behavioral interventions to COVID-19 dynamics: North Carolina county-level examples
por: Quiner, Claire, et al.
Publicado: (2022)

National polydrug use patterns among people who misuse prescription opioids and people who use heroin. Results from the National Household Survey on Drug Use and Health
por: Bobashev, Georgiy V., et al.
Publicado: (2022)

The Physician Clinical Support System-Buprenorphine (PCSS-B): a Novel Project to Expand/Improve Buprenorphine Treatment
por: Egan, James E., et al.
Publicado: (2010)

Between Care and Control: Examining Surveillance Practices in Harm Reduction
por: Michaud, Liam, et al.
Publicado: (2022)

Random forest methodology for model-based recursive partitioning: the mobForest package for R
por: Garge, Nikhil R, et al.
Publicado: (2013)

Predictive model of multiple emergency department visits among adults: analysis of the data from the National Survey of Drug Use and Health (NSDUH)
por: Bobashev, Georgiy, et al.
Publicado: (2021)

Modeling buprenorphine reduction of fentanyl-induced respiratory depression
por: Olofsen, Erik, et al.
Publicado: (2022)

Opioid Use Stigma: An Examination of Student Attitudes on Harm Reduction Strategies
por: Reynolds, Gemma, et al.
Publicado: (2022)

Sampling for Global Epidemic Models and the Topology of an International Airport Network
por: Bobashev, Georgiy, et al.
Publicado: (2008)

Are You HIV Invincible? A Probabilistic Study of Discordant Couples in the Context of HIV Transmission
por: Bobashev, Georgiy, et al.
Publicado: (2014)

“We do it ourselves”: strengths and opportunities for improving the practice of harm reduction
por: Claborn, Kasey, et al.
Publicado: (2023)

Adaptation of the Tele-Harm Reduction intervention to promote initiation and retention in buprenorphine treatment among people who inject drugs: a retrospective cohort study
por: Suarez, Edward, et al.
Publicado: (2023)

Text Analysis of Trends in Health Equity and Disparities From the Internal Revenue Service Tax Documentation Submitted by US Nonprofit Hospitals Between 2010 and 2019: Exploratory Study
por: Hadley, Emily, et al.
Publicado: (2023)

Integrating Harm Reduction into Outpatient Opioid Use Disorder Treatment Settings: Harm Reduction in Outpatient Addiction Treatment
por: Taylor, Jessica L., et al.
Publicado: (2021)

Buprenorphine
por: Mazurek, Jaroslaw, et al.
Publicado: (2014)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

Using Named Entity Recognition to Identify Substances Used in the Self-medication of Opioid Withdrawal: Natural Language Processing Study of Reddit Data
por: Preiss, Alexander, et al.
Publicado: (2022)

Modeling HIV transmission among persons who inject drugs (PWID) at the “End of the HIV Epidemic” and during the COVID-19 pandemic
por: Jarlais, Don Des, et al.
Publicado: (2022)

An Examination of the Complex Pharmacological Properties of the Non-Selective Opioid Modulator Buprenorphine
por: Pande, Leana J., et al.
Publicado: (2023)

Harm Reduction Journal
por: Drucker, Ernest
Publicado: (2004)

The Olympics and harm reduction?
por: Kayser, Bengt, et al.
Publicado: (2012)

Harm reduction in hospitals
por: Sharma, Malika, et al.
Publicado: (2017)

Decolonizing harm reduction
por: Lasco, Gideon
Publicado: (2022)

Harm reduction, methadone maintenance treatment and the root causes of health and social inequities: An intersectional lens in the Canadian context
por: Smye, Victoria, et al.
Publicado: (2011)

2440. Using a geospatially explicit agent-based model of a regional healthcare network to assess varied antibiotic risk on Clostridioides difficile infection incidence
por: Rhea, Sarah, et al.
Publicado: (2019)

Examining Attitudes and Beliefs that Inhibit Pharmacist Implementation of a Statewide Opioid Harm Reduction Program
por: Frenzel, Oliver C., et al.
Publicado: (2020)

Feasibility of needle and syringe programs in Tajikistan distributing low dead space needles
por: Zule, William A., et al.
Publicado: (2018)

Heroin type, injecting behavior, and HIV transmission. A simulation model of HIV incidence and prevalence
por: Bobashev, Georgiy, et al.
Publicado: (2019)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving
por: Ahmadi, Jamshid, et al.
Publicado: (2019)

Harm reduction-the cannabis paradox
por: Melamede, Robert
Publicado: (2005)

Prescribing cannabis for harm reduction
por: Collen, Mark
Publicado: (2012)

Harm reduction in hospitals: is it time?
por: Rachlis, Beth S, et al.
Publicado: (2009)

Disagreement, Unenforceability, and Harm Reduction
por: Weinstock, Daniel M.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bac4rju48u0hunn37e0l0sclo2